A Novel Scoring System to Assess Continence Quality Outcomes of Orthotopic Ileal Neobladders After Open and Robot-Assisted Radical Cystectomy: The Urodynamic Trifecta
Corresponding Author
Umberto Anceschi
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Correspondence: Umberto Anceschi ([email protected])
Search for more papers by this authorFabrizio Di Maida
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiuseppe Chiacchio
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorRiccardo Mastroianni
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorGabriele Tuderti
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorLuca Lambertini
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSimone Albisinni
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorManuela Mattioli
Department of Urology, “Policlinico S. Andrea” – University of Rome, Rome, Italy
Search for more papers by this authorAnna Cadenar
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSimone Flammia Rocco
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorSamuele Nardoni
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorFrancesco Prata
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorEleonora Rosato
Department of Surgical Sciences, “Policlinico Tor Vergata” – University of Rome, Rome, Italy
Search for more papers by this authorFrancesca Valastro
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAldo Brassetti
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorMara Bacchiani
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAnastasios Asimakopoulos
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorVincenzo Salamone
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSalvatore Basile
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorSofia Giudici
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiulia D'Ippolito
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorAndrea Grosso Antonio
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAntonio Tufano
Fondazione “G. Pascale” - IRCCS - Uro-Gynecological Department, Naples, Italy
Search for more papers by this authorLeslie Licari
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorEugenio Bologna
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorAndrea Mari
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAgostino Tuccio
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorEnrico Finazzi Agrò
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorCosimo De Nunzio
Department of Urology, “Policlinico S. Andrea” – University of Rome, Rome, Italy
Search for more papers by this authorRocco Papalia
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorCostantino Leonardo
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorAndrea Minervini
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiuseppe Simone
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorCorresponding Author
Umberto Anceschi
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Correspondence: Umberto Anceschi ([email protected])
Search for more papers by this authorFabrizio Di Maida
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiuseppe Chiacchio
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorRiccardo Mastroianni
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorGabriele Tuderti
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorLuca Lambertini
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSimone Albisinni
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorManuela Mattioli
Department of Urology, “Policlinico S. Andrea” – University of Rome, Rome, Italy
Search for more papers by this authorAnna Cadenar
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSimone Flammia Rocco
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorSamuele Nardoni
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorFrancesco Prata
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorEleonora Rosato
Department of Surgical Sciences, “Policlinico Tor Vergata” – University of Rome, Rome, Italy
Search for more papers by this authorFrancesca Valastro
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAldo Brassetti
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorMara Bacchiani
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAnastasios Asimakopoulos
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorVincenzo Salamone
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorSalvatore Basile
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorSofia Giudici
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiulia D'Ippolito
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorAndrea Grosso Antonio
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAntonio Tufano
Fondazione “G. Pascale” - IRCCS - Uro-Gynecological Department, Naples, Italy
Search for more papers by this authorLeslie Licari
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorEugenio Bologna
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorAndrea Mari
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorAgostino Tuccio
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorEnrico Finazzi Agrò
Department of Urology, “Policlinico Tor Vergata, Rome, Italy
Search for more papers by this authorCosimo De Nunzio
Department of Urology, “Policlinico S. Andrea” – University of Rome, Rome, Italy
Search for more papers by this authorRocco Papalia
Department of Urology, Fondazione Campus Biomedico – University of Rome, Rome, Italy
Search for more papers by this authorCostantino Leonardo
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorAndrea Minervini
Department of Urology, “AOU Careggi” – University of Florence, Florence, Italy
Search for more papers by this authorGiuseppe Simone
Department of Urologic Oncology, IRCCS “Regina Elena” National Cancer Institute (NCI), Rome, Italy
Search for more papers by this authorABSTRACT
Introduction
A comprehensive scoring system for standardizing quality of functional outcomes of orthotopic ileal neobladders (OINs) is still unavailable. In this study we propose a novel trifecta for both open and robot-assisted radical cystectomy conceived on urodynamic parameters that summarize OINs functional outcomes regardless of the surgical technique used and predicts continence status.
Materials & Methods
Between June 2017 and May 2023 two prospective, institutional review board approved, radical cystectomy datasets were matched and queried for “OINs” “and “urodynamic evaluation” (n = 149). Urodynamic assessment was performed between 6 and 9 months after surgery. Baseline data and complete urodynamic profile including uroflowmetry, cystometry, compliance, presence of residual peristaltic activity, abdominal leak point pressures (ALPP) and daytime and night-time continence were reported. Descriptive analyses were used. Frequencies and proportions were reported for categorical variables while medians and interquartile ranges (IQRs) were reported for continuously coded variables. Trifecta was defined as the coexistence of: cystometric capacity ≥ 250 cc; neobladder compliance ≥ 35 cmH20; negative Valsalva and abdominal leak point pressure testing. Simultaneous achievement of only two of the presented criteria was considered a suboptimal result. Logistic regression analyses were built to identify predictors of daytime and night-time urinary continence. For all analyses, a two-sided p < 0.05 was considered significant.
Results
Overall, at a median follow-up of 25 months (IQR 16–37), 149 patients achieved a complete urodynamic evaluation. In the current series, the complete trifecta rate was 40.2% while a suboptimal trifecta achievement was observed in 35.6% of patients. On multivariable analysis, complete trifecta achievement was the only independent predictor of daytime (OR 7.29, 95% CI 2.05–25.9) and night-time (OR 8.13; 95% CI 2.94–22.4) urinary continence, respectively (each p < 0.003). A complete UDM-T at urodynamic testing was associated with a day-time continence, night-time continence, and complete dry status rates of 93.2%, 83.1%, and 79.7%, respectively.
Conclusion
This novel urodynamic trifecta for OINs is based on standardized parameters and seems to be predictor of either daytime or night-time urinary continence at a midterm follow-up. Satisfactory continence outcomes may be also expected when a suboptimal trifecta rate is achieved.
Clinical Trial Registration
Not applicable.
Conflicts of Interest
The authors declare no conflicts of interest.
Open Research
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Supporting Information
Filename | Description |
---|---|
nau70078-sup-0001-Supplementary_Table_1.docx22.6 KB | Supplementary Table 1. |
nau70078-sup-0002-Supplementary_Table_2.docx30.3 KB | Supplementary Table 2. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1R. K. Lee, H. Abol-Enein, W. Artibani, et al., “Urinary Diversion After Radical Cystectomy for Bladder Cancer: Options, Patient Selection, and Outcomes,” BJU International 113, no. 1 (2014): 11–23, https://doi.org/10.1111/BJU.12121.
- 2M. A. Cerruto, C. D'Elia, S. Siracusano, et al., “Is Health-Related Quality of Life After Radical Cystectomy Using Validated Questionnaires Really Better in Patients With Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies,” Current Urology 10, no. 2 (2017): 57–68, https://doi.org/10.1159/000447153.
- 3F. Liedberg, G. Ahlgren, G. Baseckas, et al., “Long-Term Functional Outcomes After Radical Cystectomy With Ileal Bladder Substitute: Does the Definition of Continence Matter?,” Scandinavian Journal of Urology 51, no. 1 (2017): 44–49, https://doi.org/10.1080/21681805.2016.1249943.
- 4N. Pyrgidis, I. Sokolakis, G. Haltmair, and G. Hatzichristodoulou, “The Effect of Urinary Diversion on Renal Function After Cystectomy for Bladder Cancer: Comparison Between Ileal Conduit, Orthotopic Ileal Neobladder, and Heterotopic Ileocecal Pouch,” World Journal of Urology 40, no. 12 (2022): 3091–3097, https://doi.org/10.1007/S00345-022-04211-Z.
- 5P. Piazza, C. A. Bravi, S. Puliatti, et al., “Assessing Pentafecta Achievement After Robot-Assisted Radical Cystectomy and Its Association With Surgical Experience: Results From a High-Volume Institution,” Urologic Oncology: Seminars and Original Investigations 40, no. 6 (2022): 272.e11–272.e20, https://doi.org/10.1016/j.urolonc.2022.01.001.
- 6A. Kretschmer, T. Grimm, A. Buchner, et al., “Prognostic Features for Objectively Defined Urinary Continence After Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary Cohort,” Journal of Urology 197, no. 1 (2017): 210–215, https://doi.org/10.1016/J.JURO.2016.08.004.
- 7T. Grimm, J. Grimm, A. Buchner, et al., “Health-Related Quality of Life After Radical Cystectomy and Ileal Orthotopic Neobladder: Effect of Detailed Continence Outcomes,” World Journal of Urology 37, no. 11 (2019): 2385–2392, https://doi.org/10.1007/S00345-019-02643-8.
- 8A. Brassetti, G. Tuderti, U. Anceschi, et al., “Combined Reporting of Surgical Quality, Cancer Control and Functional Outcomes of Robot-Assisted Radical Cystectomy With Intracorporeal Orthotopic Neobladder Into a Novel Trifecta,” Minerva Urologica E Nefrologica 71, no. 6 (2019): 590–596, https://doi.org/10.23736/S0393-2249.19.03566-5.
- 9G. E. Cacciamani, M. Winter, L. G. Medina, et al., “Radical Cystectomy Pentafecta: A Proposal for Standardisation of Outcomes Reporting Following Robot-Assisted Radical Cystectomy,” BJU International 125, no. 1 (2020): 64–72, https://doi.org/10.1111/bju.14861.
- 10R. Mastroianni, G. Tuderti, M. Ferriero, et al, “Open Versus Robot-Assisted Radical Cystectomy: Pentafecta and Trifecta Achievement Comparison From a Randomised Controlled Trial,” BJU International 132, no. 6 (2023): 671–677, https://doi.org/10.1111/BJU.16134.
- 11U. Anceschi, F. Di Maida, R. S. Flammia, et al, “Robotic Intracorporeal Padua Ileal Neobladder vs. Florin Pouch: Comparison of Mid-Term Urodynamic and Functional Profiles,” Minerva Urology and Nephrology 74, no. 6 (2022): 825–827, https://doi.org/10.23736/S2724-6051.22.04884-4.
- 12E. Checcucci, M. Manfredi, M. Sica, et al., “Robot-Assisted-Radical-Cystectomy With Total Intracorporeal Y Neobladder: Analysis of Postoperative Complications and Functional Outcomes With Urodynamics Findings,” European Journal of Surgical Oncology 48, no. 3 (2022): 694–702, https://doi.org/10.1016/J.EJSO.2021.12.014.
- 13F. Di Maida, A. A. Grosso, G. Tasso, et al., “Robot Assisted Radical Cystectomy With Florence Robotic Intracorporeal Neobladder (FloRIN): Functional and Urodynamic Features Compared With a Contemporary Series of Open Vescica Ileale Padovana (VIP),” European Journal of Surgical Oncology 48, no. 8 (2022): 1854–1861, https://doi.org/10.1016/J.EJSO.2022.04.007.
- 14R. Satkunasivam, M. Santomauro, S. Chopra, et al., “Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-Related Quality of Life,” European Urology 69, no. 2 (2016): 247–253, https://doi.org/10.1016/j.eururo.2015.06.041.
- 15A. D. Asimakopoulos, M. Gubbiotti, E. F. Agrò, et al., “‘Bordeaux Neobladder’: First Evaluation of the Urodynamic Outcomes,” European Urology Open Science 47 (2023): 102–109, https://doi.org/10.1016/J.EUROS.2022.11.010.
- 16E. Grobet-Jeandin, D. Benamran, U. Pinar, et al., “Urodynamic Assessment and Quality of Life Outcomes of Robot-Assisted Totally Intracorporeal Radical Cystectomy and Orthotopic Neobladder for Bladder Cancer: A Preliminary Study,” World Journal of Urology 40, no. 10 (2022): 2535–2541, https://doi.org/10.1007/S00345-022-04126-9.
- 17M. Ferriero, G. Simone, A. Rocchegiani, et al., “Early and Late Urodynamic Assessment of Padua Ileal Bladder,” Urology 73, no. 6 (2009): 1357–1362, https://doi.org/10.1016/j.urology.2009.01.053.
- 18A. Khan, J. Vuppalapati, L. Sarath, M. Mujeeburahiman, and N. D'souza, “Functional Outcome of Robotic-Assisted Intracorporeal Versus Extracorporeal Neobladder Following Radical Cystectomy: Initial Experience,” Urology Annals 13, no. 1 (2021): 9–13, https://doi.org/10.4103/UA.UA_132_19.
- 19F. C. Burkhard, T. M. Kessler, J. Springer, and U. E. Studer, “Early and Late Urodynamic Assessment of Ileal Orthotopic Bladder Substitutes Combined With an Afferent Tubular Segment,” Journal of Urology 175, no. 6 (2006): 2155–2161, https://doi.org/10.1016/S0022-5347(06)00278-3.
- 20G. Simone, R. Papalia, L. Misuraca, et al., “Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes,” European Urology 73, no. 6 (2018): 934–940, https://doi.org/10.1016/j.eururo.2016.10.018.
- 21A. Minervini, F. Di Maida, G. Tasso, et al., “Robot Assisted Radical Cystectomy With Florence Robotic Intracorporeal Neobladder (FloRIN): Analysis of Survival and Functional Outcomes After First 100 Consecutive Patients Upon Accomplishment of Phase 3 IDEAL Framework,” European Journal of Surgical Oncology 47, no. 10 (2021): 2651–2657, https://doi.org/10.1016/j.ejso.2021.05.007.
- 22M. J. Drake, S. K. Doumouchtsis, H. Hashim, and A. Gammie, “Fundamentals of Urodynamic Practice, Based on International Continence Society Good Urodynamic Practices Recommendations,” Neurourology and Urodynamics 37 (2018): S50–S60, https://doi.org/10.1002/nau.23773.
- 23A. Gammie, B. Clarkson, C. Constantinou, et al., “International Continence Society Guidelines on Urodynamic Equipment Performance,” Neurourology and Urodynamics 33, no. 4 (2014): 370–379, https://doi.org/10.1002/NAU.22546.
- 24U. Anceschi, M. C. Ferriero, G. Tuderti, et al., “Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-Assisted Partial Nephrectomy: Results of a Multicenter Series,” European Urology Focus 7 (2021): 1391–1399, https://doi.org/10.1016/j.euf.2020.06.021.
- 25E. Lavallee, J. Sfakianos, R. Mehrazin, and P. Wiklund, “Detailed Description of the Karolinska Technique for Intracorporeal Studer Neobladder Reconstruction,” Journal of Endourology 36 (2022): S67–S72, https://doi.org/10.1089/end.2022.0248.
- 26S. Chopra, A. L. de Castro Abreu, A. K. Berger, et al., “Evolution of Robot-Assisted Orthotopic Ileal Neobladder Formation: A Step-By-Step Update to the University of Southern California (USC) Technique,” BJU International 119, no. 1 (2017): 185–191, https://doi.org/10.1111/bju.13611.
- 27J. W. F. Catto, P. Khetrapal, F. Ricciardi, et al., “Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion Vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial,” Journal of the American Medical Association 327, no. 21 (2022): 2092–2103, https://doi.org/10.1001/jama.2022.7393.
- 28R. Mastroianni, M. Ferriero, G. Tuderti, et al., “Open Radical Cystectomy Versus Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial,” Journal of Urology 207, no. 5 (2022): 982–992, https://doi.org/10.1097/JU.0000000000002422.
- 29W. D. Steers, “Voiding Dysfunction in the Orthotopic Neobladder,” World Journal of Urology 18, no. 5 (2000): 330–337, https://doi.org/10.1007/S003450000146.
- 30U. Iqbal, M. M. Durrani, A. S. Elsayed, et al., “Functional Outcomes After Robot-Assisted Radical Cystectomy: A Review of Literature,” International Journal of Urology 28, no. 5 (2021): 493–501, https://doi.org/10.1111/IJU.14495.
- 31D. Mitropoulos, W. Artibani, M. Graefen, M. Remzi, M. Rouprêt, and M. Truss, “Reporting and Grading of Complications After Urologic Surgical Procedures: An Ad Hoc EAU Guidelines Panel Assessment and Recommendations,” European Urology 61, no. 2 (2012): 341–349, https://doi.org/10.1016/j.eururo.2011.10.033.
- 32Z. Chen, G. Lu, X. Li, et al., “Better Compliance Contributes to Better Nocturnal Continence With Orthotopic Ileal Neobladder Than Ileocolonic Neobladder After Radical Cystectomy for Bladder Cancer,” Urology 73, no. 4 (2009): 838–843, https://doi.org/10.1016/J.UROLOGY.2008.09.076.
- 33E. J. McGuire, R. D. Cespedes, and H. E. O'Connell, “Leak-Point Pressures,” Urologic Clinics of North America 23, no. 2 (1996): 253–262, https://doi.org/10.1016/S0094-0143(05)70309-8.
- 34E. Finazzi Agrò, D. Bianchi, and V. Iacovelli, “Pitfalls in Urodynamics,” European Urology Focus 6, no. 5 (2020): 820–822, https://doi.org/10.1016/j.euf.2020.01.005.